Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and Asia-Pacific region.